APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Syndrome Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dry Eye Syndrome Drugs Industry Growth and Trends Forecast to 2032

23 December 2025111 pages

Choose your research edition.

Industry ResearchDry Eye Syndrome Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Syndrome Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Dry Eye Syndrome Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Syndrome Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Syndrome Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Dry Eye Syndrome Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Dry Eye Syndrome Drugs market include Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, AbbVie, URSAPHARM, Thea pharmaceuticals, Sun Pharmaceutical and SIMILASAN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dry Eye Syndrome Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dry Eye Syndrome Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dry Eye Syndrome Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dry Eye Syndrome Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Dry Eye Syndrome Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dry Eye Syndrome Drugs Market by Company

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

AbbVie

URSAPHARM

Thea pharmaceuticals

Sun Pharmaceutical

SIMILASAN

Santen Pharma

Rohto

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch & Lomb

Alcon

Akorn

Dry Eye Syndrome Drugs Segment by Type

Artificial Tears

Anti-inflammatory Drugs

Other

Dry Eye Syndrome Drugs Segment by Application

Homecare

Hospitals

Clinics

Others

Dry Eye Syndrome Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Syndrome Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Syndrome Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Syndrome Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Dry Eye Syndrome Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Dry Eye Syndrome Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Dry Eye Syndrome Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Dry Eye Syndrome Drugs Market Share by Region (2021-2026) Table 4. Global Dry Eye Syndrome Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Dry Eye Syndrome Drugs Market Share by Region (2027-2032) Table 6. Global Dry Eye Syndrome Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Dry Eye Syndrome Drugs Market Size Share by Type (2021-2026) Table 9. Global Dry Eye Syndrome Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Dry Eye Syndrome Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Dry Eye Syndrome Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Dry Eye Syndrome Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Dry Eye Syndrome Drugs Market Size Share by Application (2021-2026) Table 24. Global Dry Eye Syndrome Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Dry Eye Syndrome Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Dry Eye Syndrome Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Dry Eye Syndrome Drugs Industry Trends Table 37. Dry Eye Syndrome Drugs Industry Drivers Table 38. Dry Eye Syndrome Drugs Industry Opportunities and Challenges Table 39. Dry Eye Syndrome Drugs Industry Restraints Table 40. Global Dry Eye Syndrome Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Dry Eye Syndrome Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Dry Eye Syndrome Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Dry Eye Syndrome Drugs Key Company Headquarters & Area Served Table 44. Global Dry Eye Syndrome Drugs Company, Product Type & Application Table 45. Global Dry Eye Syndrome Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Dry Eye Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Johnson & Johnson Dry Eye Syndrome Drugs Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis Dry Eye Syndrome Drugs Product Portfolio Table 57. Novartis Recent Development Table 58. United Laboratories Company Information Table 59. United Laboratories Business Overview Table 60. United Laboratories Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. United Laboratories Dry Eye Syndrome Drugs Product Portfolio Table 62. United Laboratories Recent Development Table 63. Jianfeng Group Company Information Table 64. Jianfeng Group Business Overview Table 65. Jianfeng Group Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Jianfeng Group Dry Eye Syndrome Drugs Product Portfolio Table 67. Jianfeng Group Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AbbVie Dry Eye Syndrome Drugs Product Portfolio Table 72. AbbVie Recent Development Table 73. URSAPHARM Company Information Table 74. URSAPHARM Business Overview Table 75. URSAPHARM Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. URSAPHARM Dry Eye Syndrome Drugs Product Portfolio Table 77. URSAPHARM Recent Development Table 78. Thea pharmaceuticals Company Information Table 79. Thea pharmaceuticals Business Overview Table 80. Thea pharmaceuticals Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Thea pharmaceuticals Dry Eye Syndrome Drugs Product Portfolio Table 82. Thea pharmaceuticals Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Dry Eye Syndrome Drugs Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. SIMILASAN Company Information Table 89. SIMILASAN Business Overview Table 90. SIMILASAN Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SIMILASAN Dry Eye Syndrome Drugs Product Portfolio Table 92. SIMILASAN Recent Development Table 93. Santen Pharma Company Information Table 94. Santen Pharma Business Overview Table 95. Santen Pharma Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Santen Pharma Dry Eye Syndrome Drugs Product Portfolio Table 97. Santen Pharma Recent Development Table 98. Rohto Company Information Table 99. Rohto Business Overview Table 100. Rohto Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Rohto Dry Eye Syndrome Drugs Product Portfolio Table 102. Rohto Recent Development Table 103. Prestige Consumer Healthcare Company Information Table 104. Prestige Consumer Healthcare Business Overview Table 105. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product Portfolio Table 107. Prestige Consumer Healthcare Recent Development Table 108. OmniVision Pharma Company Information Table 109. OmniVision Pharma Business Overview Table 110. OmniVision Pharma Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. OmniVision Pharma Dry Eye Syndrome Drugs Product Portfolio Table 112. OmniVision Pharma Recent Development Table 113. LION Company Information Table 114. LION Business Overview Table 115. LION Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. LION Dry Eye Syndrome Drugs Product Portfolio Table 117. LION Recent Development Table 118. Kenvue (VISINE) Company Information Table 119. Kenvue (VISINE) Business Overview Table 120. Kenvue (VISINE) Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Kenvue (VISINE) Dry Eye Syndrome Drugs Product Portfolio Table 122. Kenvue (VISINE) Recent Development Table 123. Bausch & Lomb Company Information Table 124. Bausch & Lomb Business Overview Table 125. Bausch & Lomb Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bausch & Lomb Dry Eye Syndrome Drugs Product Portfolio Table 127. Bausch & Lomb Recent Development Table 128. Alcon Company Information Table 129. Alcon Business Overview Table 130. Alcon Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Alcon Dry Eye Syndrome Drugs Product Portfolio Table 132. Alcon Recent Development Table 133. Akorn Company Information Table 134. Akorn Business Overview Table 135. Akorn Dry Eye Syndrome Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Akorn Dry Eye Syndrome Drugs Product Portfolio Table 137. Akorn Recent Development Table 138. North America Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Dry Eye Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Dry Eye Syndrome Drugs Market Share by Country (2021-2026) Table 141. North America Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Dry Eye Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 143. Europe Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Dry Eye Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Dry Eye Syndrome Drugs Market Share by Country (2021-2026) Table 146. Europe Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Dry Eye Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Dry Eye Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Dry Eye Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Dry Eye Syndrome Drugs Market Share by Country (2021-2026) Table 156. Latin America Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Dry Eye Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2021-2026) Table 161. Middle East & Africa Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Dry Eye Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Dry Eye Syndrome Drugs Product Image Figure 3. Global Dry Eye Syndrome Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Dry Eye Syndrome Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Dry Eye Syndrome Drugs Market Share by Region (2021-2032) Figure 7. North America Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Artificial Tears Image Figure 13. Global Artificial Tears Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Anti-inflammatory Drugs Image Figure 15. Global Anti-inflammatory Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Dry Eye Syndrome Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Dry Eye Syndrome Drugs Market Share by Type 2025 VS 2032 Figure 20. North America Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032) Figure 21. Europe Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032) Figure 23. Latin America Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032) Figure 25. Homecare Image Figure 26. Global Homecare Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospitals Image Figure 28. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinics Image Figure 30. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Dry Eye Syndrome Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Dry Eye Syndrome Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032) Figure 36. Europe Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032) Figure 38. Latin America Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Dry Eye Syndrome Drugs Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Dry Eye Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Dry Eye Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 45. Europe Dry Eye Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Dry Eye Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 48. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 51. Latin America Dry Eye Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Dry Eye Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 54. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other
Applications
  • Homecare
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • AbbVie
  • URSAPHARM
  • Thea pharmaceuticals
  • Sun Pharmaceutical
  • SIMILASAN
  • Santen Pharma
  • Rohto
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch & Lomb
  • Alcon
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Dry Eye Syndrome Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Dry Eye Syndrome Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Dry Eye Syndrome Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Dry Eye Syndrome Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Dry Eye Syndrome Drugs Market Size (2021-2032)
  8. 1.5.1 North America Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate (2021-2032)
2 Dry Eye Syndrome Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Artificial Tears
  3. 2.1.2 Anti-inflammatory Drugs
  4. 2.1.3 Other
  5. 2.2 Global Dry Eye Syndrome Drugs Market Size by Type
  6. 2.2.1 Global Dry Eye Syndrome Drugs Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Dry Eye Syndrome Drugs Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Dry Eye Syndrome Drugs Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Dry Eye Syndrome Drugs Market Size by Regions
  10. 2.3.1 North America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Type (2021-2026)
3 Dry Eye Syndrome Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Homecare
  3. 3.1.2 Hospitals
  4. 3.1.3 Clinics
  5. 3.1.4 Others
  6. 3.2 Global Dry Eye Syndrome Drugs Market Size by Application
  7. 3.2.1 Global Dry Eye Syndrome Drugs Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Dry Eye Syndrome Drugs Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Dry Eye Syndrome Drugs Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Dry Eye Syndrome Drugs Market Size by Regions
  11. 3.3.1 North America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Dry Eye Syndrome Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Dry Eye Syndrome Drugs Industry Trends
  2. 4.2 Dry Eye Syndrome Drugs Industry Drivers
  3. 4.3 Dry Eye Syndrome Drugs Industry Opportunities and Challenges
  4. 4.4 Dry Eye Syndrome Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Dry Eye Syndrome Drugs Revenue (2021-2026)
  2. 5.2 Global Dry Eye Syndrome Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Dry Eye Syndrome Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Dry Eye Syndrome Drugs Company, Product Type & Application
  5. 5.5 Global Dry Eye Syndrome Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Dry Eye Syndrome Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Dry Eye Syndrome Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Dry Eye Syndrome Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Dry Eye Syndrome Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Dry Eye Syndrome Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 United Laboratories
  14. 6.3.1 United Laboratories Company Information
  15. 6.3.2 United Laboratories Business Overview
  16. 6.3.3 United Laboratories Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 United Laboratories Dry Eye Syndrome Drugs Product Portfolio
  18. 6.3.5 United Laboratories Recent Developments
  19. 6.4 Jianfeng Group
  20. 6.4.1 Jianfeng Group Company Information
  21. 6.4.2 Jianfeng Group Business Overview
  22. 6.4.3 Jianfeng Group Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Jianfeng Group Dry Eye Syndrome Drugs Product Portfolio
  24. 6.4.5 Jianfeng Group Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Dry Eye Syndrome Drugs Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 URSAPHARM
  32. 6.6.1 URSAPHARM Company Information
  33. 6.6.2 URSAPHARM Business Overview
  34. 6.6.3 URSAPHARM Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 URSAPHARM Dry Eye Syndrome Drugs Product Portfolio
  36. 6.6.5 URSAPHARM Recent Developments
  37. 6.7 Thea pharmaceuticals
  38. 6.7.1 Thea pharmaceuticals Company Information
  39. 6.7.2 Thea pharmaceuticals Business Overview
  40. 6.7.3 Thea pharmaceuticals Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Thea pharmaceuticals Dry Eye Syndrome Drugs Product Portfolio
  42. 6.7.5 Thea pharmaceuticals Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Dry Eye Syndrome Drugs Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 SIMILASAN
  50. 6.9.1 SIMILASAN Company Information
  51. 6.9.2 SIMILASAN Business Overview
  52. 6.9.3 SIMILASAN Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SIMILASAN Dry Eye Syndrome Drugs Product Portfolio
  54. 6.9.5 SIMILASAN Recent Developments
  55. 6.10 Santen Pharma
  56. 6.10.1 Santen Pharma Company Information
  57. 6.10.2 Santen Pharma Business Overview
  58. 6.10.3 Santen Pharma Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Santen Pharma Dry Eye Syndrome Drugs Product Portfolio
  60. 6.10.5 Santen Pharma Recent Developments
  61. 6.11 Rohto
  62. 6.11.1 Rohto Company Information
  63. 6.11.2 Rohto Business Overview
  64. 6.11.3 Rohto Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Rohto Dry Eye Syndrome Drugs Product Portfolio
  66. 6.11.5 Rohto Recent Developments
  67. 6.12 Prestige Consumer Healthcare
  68. 6.12.1 Prestige Consumer Healthcare Company Information
  69. 6.12.2 Prestige Consumer Healthcare Business Overview
  70. 6.12.3 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product Portfolio
  72. 6.12.5 Prestige Consumer Healthcare Recent Developments
  73. 6.13 OmniVision Pharma
  74. 6.13.1 OmniVision Pharma Company Information
  75. 6.13.2 OmniVision Pharma Business Overview
  76. 6.13.3 OmniVision Pharma Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 OmniVision Pharma Dry Eye Syndrome Drugs Product Portfolio
  78. 6.13.5 OmniVision Pharma Recent Developments
  79. 6.14 LION
  80. 6.14.1 LION Company Information
  81. 6.14.2 LION Business Overview
  82. 6.14.3 LION Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 LION Dry Eye Syndrome Drugs Product Portfolio
  84. 6.14.5 LION Recent Developments
  85. 6.15 Kenvue (VISINE)
  86. 6.15.1 Kenvue (VISINE) Company Information
  87. 6.15.2 Kenvue (VISINE) Business Overview
  88. 6.15.3 Kenvue (VISINE) Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Kenvue (VISINE) Dry Eye Syndrome Drugs Product Portfolio
  90. 6.15.5 Kenvue (VISINE) Recent Developments
  91. 6.16 Bausch & Lomb
  92. 6.16.1 Bausch & Lomb Company Information
  93. 6.16.2 Bausch & Lomb Business Overview
  94. 6.16.3 Bausch & Lomb Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bausch & Lomb Dry Eye Syndrome Drugs Product Portfolio
  96. 6.16.5 Bausch & Lomb Recent Developments
  97. 6.17 Alcon
  98. 6.17.1 Alcon Company Information
  99. 6.17.2 Alcon Business Overview
  100. 6.17.3 Alcon Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Alcon Dry Eye Syndrome Drugs Product Portfolio
  102. 6.17.5 Alcon Recent Developments
  103. 6.18 Akorn
  104. 6.18.1 Akorn Company Information
  105. 6.18.2 Akorn Business Overview
  106. 6.18.3 Akorn Dry Eye Syndrome Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Akorn Dry Eye Syndrome Drugs Product Portfolio
  108. 6.18.5 Akorn Recent Developments
7 North America
  1. 7.1 North America Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Dry Eye Syndrome Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst